Creo Medical Group (LON:CREO) Sets New 1-Year Low – Should You Sell?

Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) hit a new 52-week low during trading on Friday. The stock traded as low as GBX 9.20 and last traded at GBX 9.26, with a volume of 620,265 shares trading hands. The stock had previously closed at GBX 9.85.

Creo Medical Group Price Performance

The stock’s 50-day moving average price is GBX 10.97 and its 200-day moving average price is GBX 12.77. The company has a quick ratio of 2.19, a current ratio of 2.79 and a debt-to-equity ratio of 8.09. The company has a market capitalization of £41.59 million, a price-to-earnings ratio of -1.85 and a beta of 1.56.

Creo Medical Group (LON:CREO – Get Free Report) last announced its quarterly earnings data on Wednesday, September 30th. The company reported GBX (2) earnings per share (EPS) for the quarter. Creo Medical Group had a negative net margin of 268.57% and a negative return on equity of 38.29%. Equities research analysts anticipate that Creo Medical Group PLC will post -10.08 earnings per share for the current year.

About Creo Medical Group

(Get Free Report)

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.

Featured Articles

Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.